Piotr Pulik

Warsaw, MZ 01201, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Hospital Admission Factors Independently Affecting the Risk of Mortality of COVID-19 Patients.

Hospital Admission Factors Independently Affecting the Risk of Mortality of COVID-19 Patients.

Journal: Journal of clinical medicine

Published: August 18, 2023

Risk factors for antiretroviral therapy (ART) discontinuation in a large multinational trial of early ART initiators.

Risk factors for antiretroviral therapy (ART) discontinuation in a large multinational trial of early ART initiators.

Journal: AIDS (London, England)

Published: April 02, 2019

Meeting the WHO 90% target: antiretroviral treatment efficacy in Poland is associated with baseline clinical patient characteristics.

Meeting the WHO 90% target: antiretroviral treatment efficacy in Poland is associated with baseline clinical patient characteristics.

Journal: Journal of the International AIDS Society

Published: July 18, 2017

Efficacy and safety of nucleoside-sparing regimen based on raltegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients.

Efficacy and safety of nucleoside-sparing regimen based on raltegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients.

Journal: Journal of medical virology

Published: October 25, 2016

Dual therapy based on raltegravir and boosted protease inhibitors - the experience of Polish centers.

Dual therapy based on raltegravir and boosted protease inhibitors - the experience of Polish centers.

Journal: Archives of medical science : AMS

Published: April 23, 2016

High frequency of neurosyphilis in HIV-positive patients diagnosed with early syphilis.

High frequency of neurosyphilis in HIV-positive patients diagnosed with early syphilis.

Journal: HIV medicine

Published: July 15, 2015

Quality of life assessment among HIV-positive persons entering the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

Quality of life assessment among HIV-positive persons entering the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

Journal: HIV medicine

Published: November 21, 2014

Factors associated with the first antiretroviral therapy modification in older HIV-1 positive patients.

Factors associated with the first antiretroviral therapy modification in older HIV-1 positive patients.

Journal: AIDS research and therapy

Published: October 16, 2014

Showing 1-8 of 8

Last Updated: 09/26/2026